Carlsmed, Inc. (CARL) Tops Q4 EPS by 3c Feb 26, 2026 02:45AM
Carlsmed completes first aprevo bilateral spine fusion procedure Feb 10, 2026 09:02AM
Carlsmed reports preliminary 2025 revenue of $50.5 million Jan 12, 2026 08:08AM
Carlsmed aprevo lumbar implants show lower revision rates in spine study Jan 6, 2026 04:06PM
BTIG Reiterates Buy Rating on Carlsmed Inc (CARL) Dec 15, 2025 05:54AM


Dec 3, 2025 07:02AM Carlsmed launches aprevo cervical spine technology in U.S. market
Nov 7, 2025 04:42AM Carlsmed Inc (CARL) PT Raised to $24 at BTIG
Nov 6, 2025 06:49PM Carlsmed, Inc. (CARL) Reports Q3 Loss of $0.40
Sep 29, 2025 09:01AM Carlsmed names Jennifer Kamocsay as chief legal officer
Aug 29, 2025 06:32AM Goldman Sachs Reiterates Buy Rating on Carlsmed Inc (CARL)
Aug 18, 2025 06:05AM Truist Securities Starts Carlsmed Inc (CARL) at Buy
Aug 18, 2025 05:20AM BTIG Starts Carlsmed Inc (CARL) at Buy
Aug 18, 2025 03:47AM Piper Sandler Starts Carlsmed Inc (CARL) at Overweight
Aug 17, 2025 11:56PM Goldman Sachs Starts Carlsmed Inc (CARL) at Buy
Jul 15, 2025 06:43AM Carlsmed (CARL) Files for 6.7M Share IPO at $14-$16/sh